Genfit SA has a consensus price target of $11.5 based on the ratings of 2 analysts. The high is $13 issued by HC Wainwright & Co. on June 11, 2024. The low is $10 issued by SVB Leerink on April 11, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 11, 2024, June 6, 2024, and May 15, 2024, respectively. With an average price target of $11.67 between HC Wainwright & Co., there's an implied 158.68% upside for Genfit SA from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/11/2024 | Buy Now | 188.25% | HC Wainwright & Co. | Ed Arce | $11 → $13 | Maintains | Buy | Get Alert |
06/06/2024 | Buy Now | 143.9% | HC Wainwright & Co. | Ed Arce | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
05/15/2024 | Buy Now | 143.9% | HC Wainwright & Co. | Ed Arce | → $11 | Reiterates | Buy → Buy | Get Alert |
04/05/2024 | Buy Now | 143.9% | HC Wainwright & Co. | Ed Arce | → $11 | Reiterates | Buy → Buy | Get Alert |
12/08/2023 | Buy Now | 143.9% | HC Wainwright & Co. | Ed Arce | → $11 | Reiterates | Buy → Buy | Get Alert |
09/21/2023 | Buy Now | 143.9% | HC Wainwright & Co. | Ed Arce | → $11 | Reiterates | Buy → Buy | Get Alert |
07/03/2023 | Buy Now | 143.9% | HC Wainwright & Co. | Ed Arce | $9 → $11 | Maintains | Buy | Get Alert |
06/01/2023 | Buy Now | 99.56% | HC Wainwright & Co. | Ed Arce | → $9 | Reiterates | Buy → Buy | Get Alert |
05/24/2023 | Buy Now | 99.56% | HC Wainwright & Co. | Ed Arce | → $9 | Reiterates | Buy → Buy | Get Alert |
04/17/2023 | Buy Now | 99.56% | HC Wainwright & Co. | Ed Arce | $8 → $9 | Maintains | Buy | Get Alert |
04/11/2022 | Buy Now | 121.73% | SVB Leerink | Thomas Smith | $15 → $10 | Maintains | Outperform | Get Alert |
12/20/2021 | Buy Now | 77.38% | HC Wainwright & Co. | Ed Arce | — | Upgrade | Neutral → Buy | Get Alert |
09/30/2021 | Buy Now | 55.21% | HC Wainwright & Co. | Ed Arce | — | Maintains | Neutral | Get Alert |
The latest price target for Genfit (NASDAQ:GNFT) was reported by HC Wainwright & Co. on June 11, 2024. The analyst firm set a price target for $13.00 expecting GNFT to rise to within 12 months (a possible 188.25% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Genfit (NASDAQ:GNFT) was provided by HC Wainwright & Co., and Genfit maintained their buy rating.
The last upgrade for Genfit SA happened on December 20, 2021 when HC Wainwright & Co. raised their price target to $8. HC Wainwright & Co. previously had a neutral for Genfit SA.
There is no last downgrade for Genfit.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genfit, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genfit was filed on June 11, 2024 so you should expect the next rating to be made available sometime around June 11, 2025.
While ratings are subjective and will change, the latest Genfit (GNFT) rating was a maintained with a price target of $11.00 to $13.00. The current price Genfit (GNFT) is trading at is $4.51, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.